Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase

Uwe Haberkorn, Khashayarsha Khazaie, Iris Morr, Annette Altmann, Markus Müller, Gerhard Van Kaick

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Assessment of suicide enzyme activity would have considerable impact on the planning and the individualization of suicide gene therapy of malignant tumors. This may be done by determining the pharmacokinetics of specific substrates. We generated ganciclovir (GCV)-sensitive human mammary carcinoma cell lines after transfection with a retroviral vector bearing the herpes simplex virus thymidine kinase (HSV-tk) gene. Thereafter, uptake measurements and HPLC analyses were performed up to 48 h in an HSV-tk-expressing cell line and in a wild-type cell line using tritiated GCV. HSV-tk-expressing cells showed higher GCV uptake and phosphorylation than control cells, whereas in wild-type MCF7 cells no phosphorylated GCV was detected. In bystander experiments the total GCV uptake was related to the amount of HSV-tk- expressing cells. Furthermore, the uptake of GCV correlated closely with the growth inhibition (r = 0.92). Therefore, the accumulation of specific substrates may serve as an indicator of the HSV-tk activity and of therapy outcome. Inhibition and competition experiments demonstrated slow transport of GCV by the nucleoside carriers. The slow uptake and low affinity to HSV- tk indicate that GCV is not an ideal substrate for the nucleoside transport systems or for HSV-tk. This may be the limiting factor for therapy success, necessitating the search for better substrates of HSV-tk.

Original languageEnglish (US)
Pages (from-to)367-373
Number of pages7
JournalNuclear Medicine and Biology
Volume25
Issue number4
DOIs
StatePublished - May 1998
Externally publishedYes

Fingerprint

Ganciclovir
Thymidine Kinase
Simplexvirus
Breast Neoplasms
Nucleosides
Cell Line
Suicide
MCF-7 Cells
Genetic Therapy
Transfection
Pharmacokinetics
High Pressure Liquid Chromatography
Phosphorylation
Enzymes
Therapeutics
Growth

Keywords

  • Ganciclovir
  • Gene therapy
  • HSV thymidine kinase
  • Mammary carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. / Haberkorn, Uwe; Khazaie, Khashayarsha; Morr, Iris; Altmann, Annette; Müller, Markus; Van Kaick, Gerhard.

In: Nuclear Medicine and Biology, Vol. 25, No. 4, 05.1998, p. 367-373.

Research output: Contribution to journalArticle

Haberkorn, Uwe ; Khazaie, Khashayarsha ; Morr, Iris ; Altmann, Annette ; Müller, Markus ; Van Kaick, Gerhard. / Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. In: Nuclear Medicine and Biology. 1998 ; Vol. 25, No. 4. pp. 367-373.
@article{856eb1763c6c402ea29be1245f74ec26,
title = "Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase",
abstract = "Assessment of suicide enzyme activity would have considerable impact on the planning and the individualization of suicide gene therapy of malignant tumors. This may be done by determining the pharmacokinetics of specific substrates. We generated ganciclovir (GCV)-sensitive human mammary carcinoma cell lines after transfection with a retroviral vector bearing the herpes simplex virus thymidine kinase (HSV-tk) gene. Thereafter, uptake measurements and HPLC analyses were performed up to 48 h in an HSV-tk-expressing cell line and in a wild-type cell line using tritiated GCV. HSV-tk-expressing cells showed higher GCV uptake and phosphorylation than control cells, whereas in wild-type MCF7 cells no phosphorylated GCV was detected. In bystander experiments the total GCV uptake was related to the amount of HSV-tk- expressing cells. Furthermore, the uptake of GCV correlated closely with the growth inhibition (r = 0.92). Therefore, the accumulation of specific substrates may serve as an indicator of the HSV-tk activity and of therapy outcome. Inhibition and competition experiments demonstrated slow transport of GCV by the nucleoside carriers. The slow uptake and low affinity to HSV- tk indicate that GCV is not an ideal substrate for the nucleoside transport systems or for HSV-tk. This may be the limiting factor for therapy success, necessitating the search for better substrates of HSV-tk.",
keywords = "Ganciclovir, Gene therapy, HSV thymidine kinase, Mammary carcinoma",
author = "Uwe Haberkorn and Khashayarsha Khazaie and Iris Morr and Annette Altmann and Markus M{\"u}ller and {Van Kaick}, Gerhard",
year = "1998",
month = "5",
doi = "10.1016/S0969-8051(97)00210-2",
language = "English (US)",
volume = "25",
pages = "367--373",
journal = "International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase

AU - Haberkorn, Uwe

AU - Khazaie, Khashayarsha

AU - Morr, Iris

AU - Altmann, Annette

AU - Müller, Markus

AU - Van Kaick, Gerhard

PY - 1998/5

Y1 - 1998/5

N2 - Assessment of suicide enzyme activity would have considerable impact on the planning and the individualization of suicide gene therapy of malignant tumors. This may be done by determining the pharmacokinetics of specific substrates. We generated ganciclovir (GCV)-sensitive human mammary carcinoma cell lines after transfection with a retroviral vector bearing the herpes simplex virus thymidine kinase (HSV-tk) gene. Thereafter, uptake measurements and HPLC analyses were performed up to 48 h in an HSV-tk-expressing cell line and in a wild-type cell line using tritiated GCV. HSV-tk-expressing cells showed higher GCV uptake and phosphorylation than control cells, whereas in wild-type MCF7 cells no phosphorylated GCV was detected. In bystander experiments the total GCV uptake was related to the amount of HSV-tk- expressing cells. Furthermore, the uptake of GCV correlated closely with the growth inhibition (r = 0.92). Therefore, the accumulation of specific substrates may serve as an indicator of the HSV-tk activity and of therapy outcome. Inhibition and competition experiments demonstrated slow transport of GCV by the nucleoside carriers. The slow uptake and low affinity to HSV- tk indicate that GCV is not an ideal substrate for the nucleoside transport systems or for HSV-tk. This may be the limiting factor for therapy success, necessitating the search for better substrates of HSV-tk.

AB - Assessment of suicide enzyme activity would have considerable impact on the planning and the individualization of suicide gene therapy of malignant tumors. This may be done by determining the pharmacokinetics of specific substrates. We generated ganciclovir (GCV)-sensitive human mammary carcinoma cell lines after transfection with a retroviral vector bearing the herpes simplex virus thymidine kinase (HSV-tk) gene. Thereafter, uptake measurements and HPLC analyses were performed up to 48 h in an HSV-tk-expressing cell line and in a wild-type cell line using tritiated GCV. HSV-tk-expressing cells showed higher GCV uptake and phosphorylation than control cells, whereas in wild-type MCF7 cells no phosphorylated GCV was detected. In bystander experiments the total GCV uptake was related to the amount of HSV-tk- expressing cells. Furthermore, the uptake of GCV correlated closely with the growth inhibition (r = 0.92). Therefore, the accumulation of specific substrates may serve as an indicator of the HSV-tk activity and of therapy outcome. Inhibition and competition experiments demonstrated slow transport of GCV by the nucleoside carriers. The slow uptake and low affinity to HSV- tk indicate that GCV is not an ideal substrate for the nucleoside transport systems or for HSV-tk. This may be the limiting factor for therapy success, necessitating the search for better substrates of HSV-tk.

KW - Ganciclovir

KW - Gene therapy

KW - HSV thymidine kinase

KW - Mammary carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0031981288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031981288&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(97)00210-2

DO - 10.1016/S0969-8051(97)00210-2

M3 - Article

C2 - 9639298

AN - SCOPUS:0031981288

VL - 25

SP - 367

EP - 373

JO - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

JF - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

SN - 0969-8051

IS - 4

ER -